Uncategorized

HEALIO–Liquid biopsy test confirms remission in HPV-associated oral cancer

Liquid biopsy test confirms remission in HPV-associated oral cancer October 24, 2018 A novel liquid biopsy test showed compelling specificity and sensitivity in detecting HPV DNA among patients who underwent chemoradiotherapy for HPV-associated oropharyngeal squamous cell carcinoma, according to findings presented at the American Society for Radiation Oncology Annual Meeting. “This blood test has exceptional performance in monitoring patients for cancer recurrence after radiation therapy,” Bhisham Chera, MD, an associate professor of radiation oncology at The University of North Carolina…

0
Read More

DENTISTRY TODAY–Blood Test Confirms Remission in HPV-Associated Oral Cancer Patients

Blood Test Confirms Remission in HPV-Associated Oral Cancer Patients 25 Oct 2018 Dentistry Today   UNC Lineberger’s Bhishamjit S. Chera, MD, and Gaorav Gupta, MD, PhD. A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell carcinoma (OPSCC) are free from cancer following radiation therapy, according to researchers at the University of North Carolina (UNC) at Chapel Hill. The liquid biopsy test, which measures fragments…

0
Read More

MEDSCAPE–Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer

Liquid Biopsy Confirms Remission in HPV Oropharyngeal Cancer Roxanne Nelson, BSN, RN October 24, 2018 The so-called liquid biopsy holds great promise for detecting a variety of cancers more accurately, guiding individualized therapy, and improving monitoring during treatment. New data suggest that testing for plasma circulating tumor human papillomavirus DNA (ctHPVDNA) can be an effective method of surveillance for patients with p16-positive oropharyngeal squamous cell carcinoma (OPSCC). The performance of an optimized multianalyte ctHPVDNA blood test for detecting cancer recurrence was “exceptional,”…

0
Read More